Rapibloc 300 mg powder for solution for infusion

Licence status
Authorised: 09/02/2024
Active substances
Landiolol hydrochloride
Dosage Form
Powder for solution for infusion
Licence number
PA1353/007/001
Licence holder
Orpha-Devel Handels und Vertriebs GmbH

Product documents

Licence information

ATC code
C07AB Beta blocking agents, selective
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
09/02/2024